Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
Document Type
Journal Article
Publication Date
8-20-2015
Journal
Journal of Clinical Oncology
Volume
33
Issue
24
Inclusive Pages
2646-2654
DOI
10.1200/JCO.2014.60.1591
APA Citation
Robinson, G. W., Orr, B. A., Wu, G., Gururangan, S., Lin, T., Qaddoumi, I., . . . Gajjar, A. (2015). Vismodegib exerts targeted efficacy against recurrent sonic hedgehog - subgroup medulloblastoma: Results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032. Journal of Clinical Oncology, 33(24), 2646-2654. doi:10.1200/JCO.2014.60.1591
Peer Reviewed
1
COinS
Comments
PMCID: PMC4534527 [Available on 2016-08-20]